Characterization of a Type-Common Human Recombinant Monoclonal Antibody to Herpes Simplex Virus with High Therapeutic Potential-Reference-Cited by-同舟云学术

Characterization of a Type-Common Human Recombinant Monoclonal Antibody to Herpes Simplex Virus with High Therapeutic Potential

Published:1998-11 Issue:11 Volume:36 Page:3198-3204
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

De Logu Alessandro¹²,Williamson R. Anthony³,Rozenshteyn Roman¹,Ramiro-Ibañez Fernando¹,Simpson Cindy D.¹,Burton Dennis R.³⁴,Paolo Sanna Pietro¹

Affiliation:

1. Departments of Neuropharmacology,1

2. Sezione di Microbiologia e Virologia, Dipartimento di Scienze Chirurgiche e Trapianti d’Organo Università di Cagliari, Cagliari, Italy2

3. Immunology,3 and

4. Molecular Biology,4 The Scripps Research Institute, La Jolla, California, and

Abstract

ABSTRACT We report the characterization of a type-common human recombinant monoclonal antibody previously isolated by antigen selection from a phage-displayed combinatorial antibody library established from a herpes simplex virus (HSV)-seropositive individual. Competition with well-characterized murine monoclonal antibodies and immunodetection of gD truncations revealed that this antibody recognizes the group Ib antigenic site of glycoprotein D, a highly conserved and protective type-common determinant. To our knowledge, this is the first human group Ib monoclonal antibody ever described. The antibody also displayed first-order neutralization kinetics and a high neutralization rate constant, was capable of completely inhibiting syncytium formation by a fusogenic strain of HSV type 1, and efficiently neutralized low-passage clinical isolates of both HSV serotypes. Taken together with our earlier observations of the in vivo antiviral activities of this human recombinant antibody in animal models of HSV infection, the present results support the high therapeutic potential of this antibody.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.36.11.3198-3204.1998

Reference50 articles.

1. Arvin A. M. Prober C. G. Herpes simplex viruses Manual of clinical microbiology. Balows A. 1991 822 828 American Society for Microbiology Washington D.C

2. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2

3. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome;Birch C. J.;J. Infect. Dis.,1990

4. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro;Burioni R.;Proc. Natl. Acad. Sci. USA,1994

5. Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D;Cell Reports Medicine;2024-02

2. Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2;Virology;2024-01

3. A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice;Frontiers in Immunology;2023-05-02

4. Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity;Journal of Experimental Medicine;2022-09-26

5. Maternally transferred monoclonal antibodies protect neonatal mice from herpes simplex virus-induced mortality and morbidity;2022-01-12